Johnson & Johnson on Wednesday said that it has accelerated the first in-human clinical trial of its investigational SARS-CoV-2 vaccine in the second half of July via its Janssen Pharmaceutical Companies (Janssen).
from Times of India https://ift.tt/37lcJpt
No comments:
Post a Comment